Unknown

Dataset Information

High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease.


ABSTRACT:

Background

The molecular aetiology of inflammatory bowel disease [IBD] and its two subtypes, ulcerative colitis [UC] and Crohn's disease [CD], have been carefully investigated at genome and transcriptome levels. Recent advances in high-throughput proteome quantification has enabled comprehensive large-scale plasma proteomics studies of IBD.

Methods

The study used two cohorts: [1] The CERTIFI-cohort: 42 samples from the CERTIFI trial of anti-TNFα-refractory CD patients; [2] the PROgECT-UNITI-HCs cohort: 46 UC samples of the PROgECT study, 84 CD samples of the UNITI I and UNITI II studies, and 72 healthy controls recruited in Mount Sinai Hospital, New York, USA. The plasma proteome for these two cohorts was quantified using high-throughput platforms.

Results

For the PRO

SUBMITTER: Di Narzo AF 

PROVIDER: S-EPMC6441306 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature